Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Axios/Ipsos surveys. 1,100 U.S adults surveyed Aug. 28-31, 2020, and 1,008 U.S. adults surveyed Sept. 18-21,2020; Chart: Axios Visuals

The share of Americans eager to try a first-generation coronavirus vaccine dropped significantly in the latest installment of the Axios-Ipsos Coronavirus Index, as President Trump hyped suggestions that one could be ready before the election.

Why it matters: As the U.S. reaches a milestone of 200,000 deaths, this underscores the risks of politicizing the virus and its treatments.

  • The trend is taking place among Republicans as well as Democrats.
  • It's another warning of the potential difficulties health authorities will face in convincing enough Americans that a vaccine is safe and effective.

The big picture: Americans don't see the vaccine as a silver bullet right now. Many respondents in Week 25 of our national survey feel it's risky and at least want to wait to see how others do. And only half are prepared to pay out of pocket for it.

  • Just 13% say they'd be willing to try it immediately.
  • This all comes against the backdrop of an uncertain return-to-school experiment. One in three parents of schoolchildren says there already have been virus-related scares or outbreaks in their school district.

By the numbers: Six in 10 Americans now say they don't want to take a COVID-19 vaccine as soon as it's available, up from 53% at the end of August.

  • Their reluctance also intensified. Only 9% now say they're "very likely" to take the first-generation vaccine, down from 17% in August; 33% say they're "not at all likely" to take it, up from 26%.
  • A plurality of respondents — 30% — said they plan to get it a few months after the vaccine first becomes available
  • 13% would try to get it immediately; 16% would get it after a few weeks, 18% said they'd likely wait a year or more and 23% said they wouldn't get it at all.
  • Men remain more likely than women to take the first generation vaccine, while Black Americans are about half as likely as Hispanics or whites to take it.

Between the lines: 38% of respondents expect their health insurance to pay for them to get the vaccine if they decide to get one; 11% think the federal government will cover costs; and only 4% think they'll have to pick up the tab themselves.

  • The biggest share expect to get it from their doctor (38%), followed by a pharmacy (17%), their employer (6%) or a drive-thru (5%).

What they're saying: Cliff Young, president of Ipsos U.S. Public Affairs, says growing concerns around the vaccine reflect a combination of scientists urging patience and the "political ping-pong" of President Trump's messaging and Democrats' pushback.

  • Democrats showed the biggest drop in those saying they're likely to try the vaccine as soon as it's available, down 13 percentage points to 43%. Republicans dropped eight points, to 41%.
  • Meanwhile, independents fell just two points, to 43%. That suggests they aren't as tuned in to partisan bickering or political news.
  • "These cues, whether red or blue, immediately elicit negative emotion from the other side," Young said — creating "a negative sort of sheen" over the idea of a vaccine that's distinct from the actual science.

Methodology: This Axios/Ipsos Poll was conducted Sept. 18–21 by Ipsos’ KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,008 general population adults age 18 or older.

  • The margin of sampling error is ± 3.2 percentage points at the 95% confidence level.

Go deeper

Updated Dec 31, 2020 - Health

California reports first case of new coronavirus variant

Healthcare workers treating a patient in UCLA Medical Center in Torrence, California, on Dec. 29. Photo: Dania Maxwell/Los Angeles Times via Getty Images

California reported its first case of a new variant of the coronavirus that may be more transmissible, AP reports.

The big picture: California is the second state to document a confirmed case of the variant — which originated in the United Kingdom — after Colorado reported the first case in the United States on Tuesday.

Scoop: Border officials project 13,000 child migrants in May

The "El Chaparral" border crossing at Tijuana. Photo: Stringer/Picture Alliance via Getty Images

A Customs and Border Protection staffer told top administration officials Thursday the agency is projecting a peak of 13,000 unaccompanied children crossing the border in May, sources directly familiar with the discussion told Axios.

Why it matters: That projection would exceed the height of the 2019 crisis, which led to the infamous "kids-in-cages" disaster. It also underscores a rapidly escalating crisis for the Biden administration.

7 hours ago - World

U.S. strikes Iran-backed militia facilities in Syria

President Biden at the Pentagon on Feb. 10. Photo: Alex Brandon - Pool/Getty Images

The United States on Thursday carried out an airstrike against facilities in Syria linked to an Iran-backed militia group, the Pentagon announced.

The state of play: The strike, approved by President Biden, comes "in response to recent attacks against American and Coalition personnel in Iraq, and to ongoing threats to those personnel," Pentagon press secretary John Kirby said in a statement.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!